Terns Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $1,322 |
Gross Profit | -240 | -236 | 1,102 |
EBITDA | -25,297 | -25,364 | -23,986 |
EBIT | -25,537 | -25,600 | -24,206 |
Net Income | -22,736 | -22,373 | -21,019 |
Net Change In Cash | 0 | 0 | 1,322 |
Free Cash Flow | -16,192 | -22,827 | -19,360 |
Cash | 91,496 | 65,099 | 79,926 |
Basic Shares | 74,459 | 74,399 | 72,333 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,000 | $0 |
Gross Profit | -881 | -1,032 | 1,000 | -394 |
EBITDA | -102,558 | -60,997 | -49,348 | -36,631 |
EBIT | -102,850 | -62,029 | -49,860 | -37,025 |
Net Income | -90,210 | -60,345 | -50,158 | -40,571 |
Net Change In Cash | 0 | 0 | 1,000 | 0 |
Cost of Revenue | 95,714 | |||
Free Cash Flow | -67,442 | -49,384 | -42,167 | -30,393 |
Cash | 79,926 | 143,235 | 47,699 | 74,854 |
Basic Shares | 71,259 | 36,033 | 25,269 | 25,125 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.29 |
